Processing, please wait...
3 lectures / chairs 2 videos 2 badges

Carlos Gustavo WAMBIER's publications (50)

Commentary on picosecond Nd:YAG laser therapy for pigmentation due to lichen planus pigmentosus in a patient with skin of color.

May, 2024

read more

JAAD case reports

Comparative Long-Term Efficacy of Phenol-Croton Oil Chemical Peels for Persistent Melasma at Varied Croton tiglium Oil Concentrations.

Apr, 2024

read more

Journal of the American Academy of Dermatology

Minoxidil sulfotransferase enzymatical activity in plants: A novel paradigm in increasing minoxidil response in androgenetic alopecia.

Jan, 2024

Minoxidil is the only US FDA approved topical drug for the treatment of androgenetic alopecia (AGA). Minoxidil is effective in hair re-growth in 30%-40% of patients and 50% of males. To exert its hair growing effect, minoxidil must be sulfonated in the scalp by the minoxidil sulfotransferase enzyme (SULT1A1). Low scalp SULT1A1 correlates with lack of minoxidil response; thus, supplementing the scalp SULT1A1 with naturally occurring minoxidil sulfotransferase enzymes could potentially improve treatment outcomes in AGA patients. read more

Journal of cosmetic dermatology
Load more  

Carlos Gustavo WAMBIER's scientific societies (4)